Looks like the price is creeping up again.
Phase 3 CF trial results due out within next 3 months.
Positive result shoudl allowing marketing applications in Aust & Europe.
Market size Aust&Europe 45,000 patients
Potential take up 20% = 9,000 patients
Revenue per patient approx $13,000 (est by PXS on investor calls)
Revenue per annum potential $117m
This does not include potential US sales later
- Forums
- ASX - By Stock
- SNT
- price is creeping up
price is creeping up
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
2.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.46M |
Open | High | Low | Value | Volume |
2.3¢ | 2.4¢ | 2.3¢ | $41.05K | 1.755M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 654545 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 123383 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 654545 | 0.022 |
5 | 1736248 | 0.021 |
12 | 3101008 | 0.020 |
4 | 1315798 | 0.019 |
3 | 1002999 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 123383 | 1 |
0.025 | 43870 | 2 |
0.026 | 50000 | 1 |
0.027 | 200000 | 1 |
0.028 | 500000 | 1 |
Last trade - 15.46pm 26/06/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |